跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dobunex - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dobunex
Approved
STANDARD
Dobunex
Swiss Pharma Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b356372ace222c85
Company
Swiss Pharma Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
b356372ace222c85
Drug Approval Philippines Name
Dobunex
Product Name
Dobunex
Registration Number
DR-XY38330
Brand Name
Dobunex
Generic Name
Dobutamine (as hydrochloride)
Dosage Form
Solution For Injection
Dosage Strength
50 mg/mL (250 mg/5mL)
Manufacturer
Swiss Pharma Pvt. Ltd.
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Issuance Date
28 June 2023
Expiry Date
04 August 2028
Pharmacologic Category
Adrenergic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b356372ace222c85
Type
Standard
Back to Philippines FDA Approvals